Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Classification trees distinguish suicide attempters in major psychiatric disorders: a model of clinical decision making.

Mann JJ, Ellis SP, Waternaux CM, Liu X, Oquendo MA, Malone KM, Brodsky BS, Haas GL, Currier D.

J Clin Psychiatry. 2008 Jan;69(1):23-31.

2.

Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders.

Malone KM, Waternaux C, Haas GL, Cooper TB, Li S, Mann JJ.

Am J Psychiatry. 2003 Apr;160(4):773-9.

PMID:
12668368
3.

Meta-analysis of binary data: which within study variance estimate to use?

Chang BH, Waternaux C, Lipsitz S.

Stat Med. 2001 Jul 15;20(13):1947-56.

PMID:
11427951
4.

The Yugoslavia Prospective Lead Study: contributions of prenatal and postnatal lead exposure to early intelligence.

Wasserman GA, Liu X, Popovac D, Factor-Litvak P, Kline J, Waternaux C, LoIacono N, Graziano JH.

Neurotoxicol Teratol. 2000 Nov-Dec;22(6):811-8.

PMID:
11120386
5.

Modelling the decline pattern in functional measures from a prevalent cohort study.

Liu X, Teresi JA, Waternaux C.

Stat Med. 2000 Jun 15-30;19(11-12):1593-606.

PMID:
10844721
6.

Suicidal behavior in bipolar mood disorder: clinical characteristics of attempters and nonattempters.

Oquendo MA, Waternaux C, Brodsky B, Parsons B, Haas GL, Malone KM, Mann JJ.

J Affect Disord. 2000 Aug;59(2):107-17.

PMID:
10837879
7.

Psychological versus pharmacological treatments of bulimia nervosa: predictors and processes of change.

Wilson GT, Loeb KL, Walsh BT, Labouvie E, Petkova E, Liu X, Waternaux C.

J Consult Clin Psychol. 1999 Aug;67(4):451-9.

PMID:
10450615
8.

Toward a clinical model of suicidal behavior in psychiatric patients.

Mann JJ, Waternaux C, Haas GL, Malone KM.

Am J Psychiatry. 1999 Feb;156(2):181-9.

PMID:
9989552
9.

Quantifying the speed of symptomatic improvement with electroconvulsive therapy: comparison of alternative statistical methods.

Nobler MS, Sackeim HA, Moeller JR, Prudic J, Petkova E, Waternaux C.

Convuls Ther. 1997 Dec;13(4):208-21.

PMID:
9437565
10.

Medication and psychotherapy in the treatment of bulimia nervosa.

Walsh BT, Wilson GT, Loeb KL, Devlin MJ, Pike KM, Roose SP, Fleiss J, Waternaux C.

Am J Psychiatry. 1997 Apr;154(4):523-31.

PMID:
9090340
11.

Thought disorder in adolescent-onset schizophrenia.

Makowski D, Waternaux C, Lajonchere CM, Dicker R, Smoke N, Koplewicz H, Min D, Mendell NR, Levy DL.

Schizophr Res. 1997 Feb 7;23(2):147-65.

PMID:
9061811
12.

Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls.

Yurgelun-Todd DA, Renshaw PF, Gruber SA, Ed M, Waternaux C, Cohen BM.

Schizophr Res. 1996 Mar;19(1):55-9.

PMID:
9147496
13.

Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production.

Yurgelun-Todd DA, Waternaux CM, Cohen BM, Gruber SA, English CD, Renshaw PF.

Am J Psychiatry. 1996 Feb;153(2):200-5.

PMID:
8561199
14.

A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients.

Inderbitzin LB, Lewine RR, Scheller-Gilkey G, Swofford CD, Egan GJ, Gloersen BA, Vidanagama BP, Waternaux C.

Am J Psychiatry. 1994 Dec;151(12):1753-9.

PMID:
7977881
15.

One hundred years of schizophrenia: a meta-analysis of the outcome literature.

Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G.

Am J Psychiatry. 1994 Oct;151(10):1409-16.

PMID:
8092334
16.

Obstetrical complications and trail making deficits discriminate schizophrenics from unaffected siblings and controls.

Kinney DK, Yurgelun-Todd DA, Waternaux CM, Matthysse S.

Schizophr Res. 1994 Apr;12(1):63-73.

PMID:
8018586
17.

Empirical determination of thresholds for case identification: validation of the Personality Diagnostic Questionnaire-Revised.

Yeung AS, Lyons MJ, Waternaux CM, Faraone SV, Tsuang MT.

Compr Psychiatry. 1993 Nov-Dec;34(6):384-91.

PMID:
8131382
18.

Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset.

Gibbons RD, Hedeker D, Elkin I, Waternaux C, Kraemer HC, Greenhouse JB, Shea MT, Imber SD, Sotsky SM, Watkins JT.

Arch Gen Psychiatry. 1993 Sep;50(9):739-50.

PMID:
8357299
19.

A family study of self-reported personality traits and DSM-III-R personality disorders.

Yeung AS, Lyons MJ, Waternaux CM, Faraone SV, Tsuang MT.

Psychiatry Res. 1993 Sep;48(3):243-55.

PMID:
8272446
20.

The relationship between DSM-III personality disorders and the five-factor model of personality.

Yeung AS, Lyons MJ, Waternaux CM, Faraone SV, Tsuang MT.

Compr Psychiatry. 1993 Jul-Aug;34(4):227-34.

PMID:
8348800
21.

Haloperidol response and plasma catecholamines and their metabolites.

Green AI, Alam MY, Boshes RA, Waternaux C, Pappalardo KM, Fitzgibbon ME, Tsuang MT, Schildkraut JJ.

Schizophr Res. 1993 Jun;10(1):33-7.

PMID:
8369230
22.

Clozapine response and plasma catecholamines and their metabolites.

Green AI, Alam MY, Sobieraj JT, Pappalardo KM, Waternaux C, Salzman C, Schatzberg AF, Schildkraut JJ.

Psychiatry Res. 1993 Feb;46(2):139-49. Review.

PMID:
8483973
23.

Mothers of sexually abused children: trauma and repair in longitudinal perspective.

Newberger CM, Gremy IM, Waternaux CM, Newberger EH.

Am J Orthopsychiatry. 1993 Jan;63(1):92-102.

PMID:
8427316
24.

Good sleep, bad sleep: a meta-analysis of polysomnographic measures in insomnia, depression, and narcolepsy.

Hudson JI, Pope HG, Sullivan LE, Waternaux CM, Keck PE, Broughton RJ.

Biol Psychiatry. 1992 Dec 1;32(11):958-75.

PMID:
1467388
25.

Side effects and the "blindability" of clinical drug trials.

White K, Kando J, Park T, Waternaux C, Brown WA.

Am J Psychiatry. 1992 Dec;149(12):1730-1.

PMID:
1443253
26.

Normal eye tracking is associated with abnormal morphology of medial temporal lobe structures in schizophrenia.

Levy DL, Bogerts B, Degreef G, Dorogusker B, Waternaux C, Ashtari M, Jody D, Geisler S, Lieberman JA.

Schizophr Res. 1992 Oct;8(1):1-10.

PMID:
1419933
27.

Polysomnographic characteristics of young manic patients. Comparison with unipolar depressed patients and normal control subjects.

Hudson JI, Lipinski JF, Keck PE Jr, Aizley HG, Lukas SE, Rothschild AJ, Waternaux CM, Kupfer DJ.

Arch Gen Psychiatry. 1992 May;49(5):378-83. Erratum in: Arch Gen Psychiatry 1993 Jan;50(1):77.

PMID:
1586273
28.

Pre-natal blood lead levels and learning difficulties in children: an analysis of non-randomly missing categorical data.

Conaway MR, Waternaux C, Allred E, Bellinger D, Leviton A.

Stat Med. 1992 Apr;11(6):799-811.

PMID:
1594818
29.

Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressants.

Mooney JJ, Schatzberg AF, Cole JO, Samson JA, Waternaux C, Gerson B, Pappalardo KM, Schildkraut JJ.

J Clin Psychopharmacol. 1991 Dec;11(6):339-43.

PMID:
1770151
30.

Episode sequence in bipolar disorder and response to lithium treatment.

Faedda GL, Baldessarini RJ, Tohen M, Strakowski SM, Waternaux C.

Am J Psychiatry. 1991 Sep;148(9):1237-9. No abstract available.

PMID:
1883005
31.

Effects of lithium treatment on eye movements.

Holzman PS, O'Brian C, Waternaux C.

Biol Psychiatry. 1991 May 15;29(10):1001-15.

PMID:
2065136
32.

Low-level lead exposure and children's cognitive function in the preschool years.

Bellinger D, Sloman J, Leviton A, Rabinowitz M, Needleman HL, Waternaux C.

Pediatrics. 1991 Feb;87(2):219-27. Erratum in: Pediatrics 1994 Feb;93(2):A28.

PMID:
1987535
33.

Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis.

Tohen M, Waternaux CM, Tsuang MT.

Arch Gen Psychiatry. 1990 Dec;47(12):1106-11.

PMID:
2244795
34.

Four-year follow-up of twenty-four first-episode manic patients.

Tohen M, Waternaux CM, Tsuang MT, Hunt AT.

J Affect Disord. 1990 Jun;19(2):79-86.

PMID:
2142702
35.

Lead, IQ and social class.

Bellinger D, Leviton A, Waternaux C.

Int J Epidemiol. 1989 Mar;18(1):180-5.

PMID:
2722362
36.

Investigating drug plasma levels and clinical response using random regression models.

Hedeker D, Gibbons RD, Waternaux C, Davis JM.

Psychopharmacol Bull. 1989;25(2):227-31.

PMID:
2602516
37.

A fixed dose study of the plasma concentration and clinical effects of thioridazine and its major metabolites.

Cohen BM, Lipinski JF, Waternaux C.

Psychopharmacology (Berl). 1989;97(4):481-8.

PMID:
2498945
38.

Low-level lead exposure, social class, and infant development.

Bellinger D, Leviton A, Waternaux C, Needleman H, Rabinowitz M.

Neurotoxicol Teratol. 1988 Nov-Dec;10(6):497-503.

PMID:
3244341
39.

S-adenosylmethionine in depression. A literature review and preliminary report.

Janicak PG, Lipinski J, Davis JM, Comaty JE, Waternaux C, Cohen B, Altman E, Sharma RP.

Ala J Med Sci. 1988 Jul;25(3):306-13. Review. No abstract available.

PMID:
3052139
40.

Symptoms and functioning of patients with bipolar disorder six months after hospitalization.

Dion GL, Tohen M, Anthony WA, Waternaux CS.

Hosp Community Psychiatry. 1988 Jun;39(6):652-7.

PMID:
3402925
41.

Random regression models: a comprehensive approach to the analysis of longitudinal psychiatric data.

Gibbons RD, Hedeker D, Waternaux C, Davis JM.

Psychopharmacol Bull. 1988;24(3):438-43. No abstract available.

PMID:
3153505
42.

Methodology in psychiatric research. Report on the 1986 MacArthur Foundation Network I Methodology Institute.

Kraemer HC, Pruyn JP, Gibbons RD, Greenhouse JB, Grochocinski VJ, Waternaux C, Kupfer DJ.

Arch Gen Psychiatry. 1987 Dec;44(12):1100-6.

PMID:
3689097
43.

Adrenoceptors and the pharmacology of affective illness: a unifying theory.

Lipinski JF Jr, Cohen BM, Zubenko GS, Waternaux CM.

Life Sci. 1987 May 18;40(20):1947-63. Review. Erratum in: Life Sci 1987 Jul 13;41(2):249.

PMID:
2883548
44.

Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development.

Bellinger D, Leviton A, Waternaux C, Needleman H, Rabinowitz M.

N Engl J Med. 1987 Apr 23;316(17):1037-43.

PMID:
3561456
45.

High rate of affective disorders in probands with attention deficit disorder and in their relatives: a controlled family study.

Biederman J, Munir K, Knee D, Armentano M, Autor S, Waternaux C, Tsuang M.

Am J Psychiatry. 1987 Mar;144(3):330-3.

PMID:
3826433
46.

Presentation of growth velocities of rural Haitian children using smoothing spline techniques.

Waternaux C, Hebert JR, Dawson R, Berggren GG.

Growth. 1987 Spring;51(1):154-64.

PMID:
3623190
47.

Prosthetic valve endocarditis. Analysis of factors affecting outcome of therapy.

Calderwood SB, Swinski LA, Karchmer AW, Waternaux CM, Buckley MJ.

J Thorac Cardiovasc Surg. 1986 Oct;92(4):776-83.

PMID:
3762207
48.

Correlates of low-level lead exposure in urban children at 2 years of age.

Bellinger D, Leviton A, Rabinowitz M, Needleman H, Waternaux C.

Pediatrics. 1986 Jun;77(6):826-33.

PMID:
3714374
49.

Low-level lead exposure and infant development in the first year.

Bellinger D, Leviton A, Needleman HL, Waternaux C, Rabinowitz M.

Neurobehav Toxicol Teratol. 1986 Mar-Apr;8(2):151-61.

PMID:
2423895
50.

A family study of patients with attention deficit disorder and normal controls.

Biederman J, Munir K, Knee D, Habelow W, Armentano M, Autor S, Hoge SK, Waternaux C.

J Psychiatr Res. 1986;20(4):263-74.

PMID:
3806422

Supplemental Content

Loading ...
Support Center